Stockscreener 앱 받기
25.22
4.97%
-1.32
시장 영업 전:
25.69
0.47
+1.86%
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
BVF Inc. IL Has $65.28 Million Stock Position in XOMA Royalty Corporation $XOMA - MarketBeat
XOMA stock maintains Buy rating at Benchmark despite partner’s trial setback - Investing.com
XOMA: HC Wainwright Maintains Buy Rating, Lowers Price Target to $97 | XOMA Stock News - GuruFocus
Leerink Partners lowers XOMA stock price target on RZ358 trial failure By Investing.com - Investing.com South Africa
HC Wainwright & Co. Maintains XOMA Royalty (XOMA) Buy Recommendation - Nasdaq
Why two Bay Area companies' stocks tumbled on a drug's clinical failure - The Business Journals
XOMA stock price target lowered to $97 by H.C. Wainwright - Investing.com Australia
XOMA: Leerink Partners Lowers Price Target, Reiterates Outperfor - GuruFocus
Why Is XOMA Royalty Stock Sinking Thursday? - Benzinga
Leerink Partners lowers XOMA stock price target on RZ358 trial failure - Investing.com
LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
Lucid Capital Markets initiates coverage on XOMA stock with Buy rating - Investing.com Canada
XOMA Royalty (XOMA): New Buy Rating Initiated by Lucid Capital M - GuruFocus
Mural Oncology Announces Sanction of the Scheme by the High Court - 富途牛牛
XOMA (NASDAQ:XOMAO) Trading 0.8% Higher – Time to Buy? - Defense World
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria
Xoma announces closing of transaction to acquire Mural Oncology - TipRanks
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree
Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - The Manila Times
Mural Oncology Plc Completes Acquisition by XRA 5 Corp. - TipRanks
XOMA Royalty completes acquisition of Mural Oncology - Investing.com India
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Why XOMA Royalty Corporation (X0M1) stock could be top winnerJuly 2025 Outlook & Weekly High Return Stock Opportunities - Newser
Will XOMA Royalty Corporation (X0M1) stock test record highs in 20252025 Price Action Summary & Weekly High Return Forecasts - Newser
Why XOMA Royalty Corporation (X0M1) stock appeals to dividend investorsEarnings Recap Report & Capital Efficient Trade Techniques - Newser
What earnings margins imply for XOMA Royalty Corporation(X0M) stockIPO Watch & Risk Managed Investment Strategies - Newser
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com India
Irish court approves XOMA Royalty’s acquisition of Mural Oncology - Investing.com
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) wins Irish court nod for XOMA deal, Nasdaq trading expected to end Dec. 4 - Stock Titan
Is XOMA Royalty Corporation (X0M1) stock a defensive play amid uncertaintyMarket Activity Summary & Weekly Watchlist for Consistent Profits - Newser
How robust is XOMA Royalty Corporation(X0M) stock financial position - Newser
XOMA Royalty (NASDAQ:XOMA) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Mural Oncology Shareholders To Receive $2.035 Cash Per Share In XOMA Royalty Acquisition - Nasdaq
Mural Oncology announces final cash consideration payable on acquisition close - MSN
XOMA Royalty to acquire Mural Oncology for $2.035 per share By Investing.com - Investing.com Nigeria
XOMA Royalty to acquire Mural Oncology for $2.035 per share - Investing.com India
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - The Globe and Mail
Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan
XOMA (NASDAQ:XOMAP) Trading 0.2% Higher – Should You Buy? - Defense World
Xoma completes $24.9M acquisition of cash-strapped Lava Therapeutics - The Business Journals
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - ADVFN
Xoma announces closing of transactions to acquire Lava Therapeutics - TipRanks
1.08%
0.91%
자본화:
|
볼륨(24시간):